HHS Prepares To Procure Hard-To-Find Ventilator-Associated Medicines For COVID-19 Patients
With $2b of ventilators on order for national stockpile, department begins search for pharmaceuticals the ventilated ICU patients will require.
You may also be interested in...
Vials arrive in fits and starts, often in wrong sizes, as allocation quotas, quality issues and difficulty anticipating surges wreak havoc in pharmaceutical supply chain.
If the US FDA could track production, it could anticipate shortages – and national security threats from countries like China.
Agency may share outcomes of remote record reviews in lieu of inspections at US and foreign facilities.